Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Squamous Non-Small Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02027428
What this trial is testing

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Who this might be right for
Squamous Cell Carcinoma, Non-Small-Cell Lung
Celgene 427
Testing effectiveness (Phase 2)Ended earlyNCT00776100
What this trial is testing

Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04497584
What this trial is testing

Phase 2 Trial of Afatinib Plus Prednisone for Advanced Squamous NSCLC

Who this might be right for
Advanced Squamous Non Small Cell Lung Cancer
University of Texas Southwestern Medical Center 12
Not applicableStudy completedNCT04490564
What this trial is testing

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerMelanoma
Pharmassist Ltd 135
Post-approval studies (Phase 4)Study completedNCT01066884
What this trial is testing

First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 5
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Not applicableWithdrawnNCT04941365
What this trial is testing

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

Who this might be right for
Metastatic MelanomaMetastatic Breast CancerAdvanced Renal Cell Carcinoma+3 more
Institut du Cancer de Montpellier - Val d'Aurelle
Testing effectiveness (Phase 2)Ended earlyNCT00260598
What this trial is testing

LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaHead and Neck Squamous Cell CancerPulmonary Disease, Chronic Obstructive
University of Pittsburgh 142
Not applicableStudy completedNCT03132493
What this trial is testing

Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient

Who this might be right for
Non Small Cell Lung Cancer
Spanish Lung Cancer Group 676
Post-approval studies (Phase 4)UnknownNCT02996214
What this trial is testing

Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)

Who this might be right for
Squamous Non-small-cell Lung Cancer
Nanjing Luye Sike Pharmaceutical Co., Ltd. 536
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Testing effectiveness (Phase 2)Study completedNCT00002506
What this trial is testing

Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer

Who this might be right for
Cervical CancerEsophageal CancerHead and Neck Cancer+3 more
Hoag Memorial Hospital Presbyterian
Not applicableStudy completedNCT02695849
What this trial is testing

Prevalence of EGFR Mutations in Participants With NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 69
Testing effectiveness (Phase 2)Study completedNCT00003666
What this trial is testing

Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 36
Large-scale testing (Phase 3)Study completedNCT02409342
What this trial is testing

Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 572
Testing effectiveness (Phase 2)Ended earlyNCT05513703
What this trial is testing

Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants With Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
AbbVie 9
Not applicableUnknownNCT04137588
What this trial is testing

Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Advanced Non-squamous Non-small Cell Lung Cancer
Peking University Cancer Hospital & Institute 126
Large-scale testing (Phase 3)UnknownNCT01303926
What this trial is testing

Quality of Life Comparison in Advanced Non-squamous Non Small Cell Lung Cancer

Who this might be right for
Non-squamous Nonsmall Cell Neoplasm of Lung
Gruppo Oncologico Italia Meridionale 118
Testing effectiveness (Phase 2)Active Not RecruitingNCT06246110
What this trial is testing

EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

Who this might be right for
NSCLC
Eikon Therapeutics 70
Testing effectiveness (Phase 2)Study completedNCT01532089
What this trial is testing

Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

Who this might be right for
EGFR Exon 19 Deletion MutationEGFR NP_005219.2:p.L858RLung Non-Squamous Non-Small Cell Carcinoma+1 more
Academic and Community Cancer Research United 88
Next Page